Global Zinc Methionie Chelates Market, By Product (Food Grade, Feed Grade), End Users (Bovine, Poultry, Swine, Equine, Aqua, Pets, Others), Country (U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Global zinc methionie chelates market size is expected to grow at a compound annual rate of 6.7% in the forecast period 2021 to 2028 and is likely to reach USD 19.32 billion by 2028. The rise in the product acceptance and usage is the factor responsible for the growth of zinc methionie chelates market in the forecast period of 2021 to 2028.
Chelated zinc are basically zinc supplements which are primarily used for treating zinc deficiency in animals and humans. Chelated minerals consists oforganic minerals, water -soluble product which is why they are easily absorbed. The various functions of zinc methionine chelate in animals are boost immunity, skin and hoof integrity, muscle development, milk production, reproduction.
The increasing awarenessand zinc deficiency amongst customers regarding nutritional supplements of zinc methionie chelates for both humans and animals is estimated to heighten the overall demand for the global zinc methionine chelates market over the forecast period. The rise in the consumer spending, high consumption of animal product and flourishing animal feed industry are also likely to boost the market growth. The increase in demand for good quality meat or poultry products and the reduced performance and reproduction activities of overall increases the market demand which is expected to further generate new opportunities for the global zinc methionie chelates market in the forecast period of 2021 to 2028.
However, the high cost is projected to act as a restraint towards the growth whereas rise in allergic population to zinc methionine chelates is estimated to be a challenge to the growth of the market.